Skip to main content

Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients

Abstract

Objective

To evaluate outcomes and predictors of survival of pediatric thyroid carcinoma, specifically papillary thyroid carcinoma.

Methods

SEER was searched for surgical pediatric cases (≤20 years old) of papillary thyroid carcinoma diagnosed between 1973 and 2011. Demographics, clinical characteristics, and survival outcomes were analyzed using standard statistical methods. All papillary types, including follicular variant, were included.

Results

A total of 2504 cases were identified. Overall incidence was 0.483/100,000 persons per year with a significant annual percent change (APC) in occurrence of 2.07 % from baseline (P < 0.05). Mean age at diagnosis was 16 years and highest incidence was found in white, female patients ages 15–19. Patients with tumor sizes <1 cm more likely received lobectomies/isthmusectomies versus subtotal/total thyroidectomies [OR = 3.03 (2.12, 4.32); P < 0.001]. Patients with tumors ≥1 cm and lymph node-positive statuses [OR = 99.0 (12.5, 783); P < 0.001] more likely underwent subtotal/total thyroidectomy compared to lobectomy/isthmusectomy. Tumors ≥1 cm were more likely lymph node-positive [OR = 39.4 (16.6, 93.7); p < 0.001]. Mortality did not differ between procedures. Mean survival was 38.6 years and higher in those with regional disease. Disease-specific 30-year survival ranged from 99 to 100 %, regardless of tumor size or procedure. Lymph node sampling did not affect survival.

Conclusions

The incidence of pediatric papillary thyroid cancer is increasing. Females have a higher incidence, but similar survival to males. Tumors ≥1 cm were likely to be lymph node-positive. Although tumors ≥1 cm were more likely to be resected by subtotal/total thyroidectomy, survival was high and did not differ based on procedure.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Collini P, Massimino M, Leite SF et al (2006) Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the istituto nazionale tumori in milan. Pediatr Blood Cancer 46:300–306

    Article  PubMed  Google Scholar 

  2. 2.

    Dinauer CA, Breuer C, Rivkees SA (2008) Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol 20:59–65

    Article  PubMed  Google Scholar 

  3. 3.

    Luster M, Lassmann M, Freudenberg LS et al (2007) Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. Hormones 6:269–278

    Article  PubMed  Google Scholar 

  4. 4.

    Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 156:167–172

    Article  PubMed  Google Scholar 

  5. 5.

    Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202

    Article  PubMed  Google Scholar 

  6. 6.

    Dzepina D (2012) Surgical and pathological characteristics of papillary thyroid cancer in children and adolescents. Int J Pediatr 2012:125389

    PubMed Central  Article  PubMed  Google Scholar 

  7. 7.

    Grigsby PW, Gal-or A, Michalski JM et al (2002) Childhood and adolescent thyroid carcinoma. Cancer 95:724–729

    Article  PubMed  Google Scholar 

  8. 8.

    Diesen DL, Skinner MA (2012) Pediatric thyroid cancer. Semin Pediatr Surg 21:44–50

    Article  PubMed  Google Scholar 

  9. 9.

    Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166

    CAS  PubMed  Google Scholar 

  10. 10.

    Spinelli C, Bertocchini A, Antonelli A et al (2004) Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or = 16 years old. J Pediatr Surg 39:1500–1505

    Article  PubMed  Google Scholar 

  11. 11.

    La Quaglia MP, Black T, Holcomb GW 3rd et al (2000) Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the surgical discipline committee of the children’s cancer group. J Pediatr Surg 35:955–959 (discussion 960)

    Article  PubMed  Google Scholar 

  12. 12.

    Cady B (1998) Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 124:947–957

    Article  CAS  PubMed  Google Scholar 

  13. 13.

    Bal CS, Padhy AK, Kumar A (2001) Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-himalayan iodine-deficient endemic zone. Nucl Med Commun 22:881–887

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    Schlumberger M, Tubiana M, De Vathaire F et al (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960–967

    Article  CAS  PubMed  Google Scholar 

  15. 15.

    La Quaglia MP, Corbally MT, Heller G et al (1988) Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 104:1149–1156

    PubMed  Google Scholar 

  16. 16.

    Brink JS, van Heerden JA, McIver B et al (2000) Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 128:881–886 (discussion 886-887)

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Perez EA, Gutierrez JC, Koniaris LG et al (2009) Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg 44:197–203

    Article  PubMed  Google Scholar 

  18. 18.

    McAteer JP, Huaco JA, Gow KW (2013) Predictors of survival in pediatric adrenocortical carcinoma: a surveillance, epidemiology, and end results (seer) program study. J Pediatr Surg 48:1025–1031

    Article  PubMed  Google Scholar 

  19. 19.

    Gutierrez JC, Fischer AC, Sola JE et al (2007) Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Pediatr Surg Int 23:637–646

    Article  PubMed  Google Scholar 

  20. 20.

    Yang R, Cheung MC, Zhuge Y et al (2010) Primary solid tumors of the colon and rectum in the pediatric patient: a review of 270 cases. J Surg Res 161:209–216

    Article  PubMed  Google Scholar 

  21. 21.

    Allan BJ, Wang B, Davis JS et al (2014) A review of 218 pediatric cases of hepatocellular carcinoma. J Pediatr Surg 49:166–171

    Article  PubMed  Google Scholar 

  22. 22.

    Allan BJ, Parikh PP, Diaz S et al (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford). 15:741–746

    PubMed Central  Article  PubMed  Google Scholar 

  23. 23.

    Allan BJ, Thorson CM, Davis JS et al (2013) An analysis of 73 cases of pediatric malignant tumors of the thymus. J Surg Res 184:397–403

    Article  PubMed  Google Scholar 

  24. 24.

    Davis JS, Allan BJ, Perez EA et al (2013) Primary pediatric cardiac malignancies: the seer experience. Pediatr Surg Int 29:425–429

    Article  PubMed  Google Scholar 

  25. 25.

    Kassira N, Pedroso FE, Cheung MC et al (2011) Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the seer registry. J Pediatr Surg 46:1956–1964

    Article  PubMed  Google Scholar 

  26. 26.

    Young JL Jr, Percy CL, Asire AJ et al (1981) Cancer incidence and mortality in the United States, 1973–77. Natl Cancer Inst Monogr 57:1–187

    PubMed  Google Scholar 

  27. 27.

    Harness JK (1997) Childhood thyroid carcinoma. In: Clark OH, Duh Q-Y (eds) Textbook of endocrine surgery. Saunders, Philadelphia pp 75–81

    Google Scholar 

  28. 28.

    Tucker MA, Jones PH, Boice JD Jr et al (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. The late effects study group. Cancer Res 51:2885–2888

    CAS  PubMed  Google Scholar 

  29. 29.

    Thompson GB, Hay ID (2004) Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg 28:1187–1198

    Article  PubMed  Google Scholar 

  30. 30.

    Wiersinga WM (2007) Management of thyroid nodules in children and adolescents. Hormones 6:194–199

    PubMed  Google Scholar 

  31. 31.

    Harach HR, Williams ED (1995) Childhood thyroid cancer in england and wales. Br J Cancer 72:777–783

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  32. 32.

    Newman KD, Black T, Heller G et al (1998) Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the surgical discipline committee of the children’s cancer group. Ann Surg 227:533–541

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  33. 33.

    Collini P, Mattavelli F, Pellegrinelli A et al (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420–1426

    Article  PubMed  Google Scholar 

  34. 34.

    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

    Article  CAS  PubMed  Google Scholar 

  35. 35.

    Massimino M, Collini P, Leite SF et al (2006) Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 46:307–313

    Article  PubMed  Google Scholar 

  36. 36.

    Farrar WB, Cooperman M, James AG (1980) Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg 192:701–704

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  37. 37.

    Gemsenjager E, Heitz PU, Martina B (1997) Selective treatment of differentiated thyroid carcinoma. World J Surg 21:546–551

    Article  CAS  PubMed  Google Scholar 

  38. 38.

    Hay ID, McConahey WM, Goellner JR (2002) Managing patients with papillary thyroid carcinoma: insights gained from the mayo clinic’s experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113:241–260

    PubMed Central  PubMed  Google Scholar 

  39. 39.

    Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050–1057

    CAS  PubMed  Google Scholar 

  40. 40.

    Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the mayo clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885

    Article  PubMed  Google Scholar 

  41. 41.

    Adam MA, Pura J, Gu L et al (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–605

    PubMed Central  Article  PubMed  Google Scholar 

  42. 42.

    Nemec JZV, Pohunkova D et al (1986) Some factors influencing the survival of patients with less advanced stages of differentiated thyroid cancer. Endocrinol Exp. 20:85–95

    CAS  PubMed  Google Scholar 

  43. 43.

    Demidchik Iu E, Kontratovich VA (2003) Repeat surgery for recurrent thyroid cancer in children. Vopr Onkol 49:366–369

    CAS  PubMed  Google Scholar 

  44. 44.

    Chan AC, Lang BH, Wong KP (2013) The pros and cons of routine central compartment neck dissection for clinically nodal negative (cn0) papillary thyroid cancer. Gland Surg 2:186–195

    PubMed Central  PubMed  Google Scholar 

  45. 45.

    Schneider DF, Mazeh H, Chen H et al (2013) Lymph node ratio predicts recurrence in papillary thyroid cancer. Oncologist 18:157–162

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  46. 46.

    Landau D, Vini L, A’Hern R et al (2000) Thyroid cancer in children: the royal marsden hospital experience. Eur J Cancer 36:214–220

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Anthony R. Hogan.

Ethics declarations

Conflict of interest

None.

Author contributions

JES, JIL, ARH, and EAP contributed to study conception and design. SG, JT, and EAP contributed to acquisition, analysis and interpretation of data. SG, JT, JES, ARH, and EAP contributed to drafting of manuscript. All authors contributed to critical revision of manuscript.

Financial disclosures

No authors have any financial affiliations to disclose.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Golpanian, S., Perez, E.A., Tashiro, J. et al. Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int 32, 201–208 (2016). https://doi.org/10.1007/s00383-015-3855-0

Download citation

Keywords

  • Pediatric
  • Papillary thyroid carcinoma
  • Survival
  • Subtotal/total thyroidectomy
  • Lymphadenectomy